Jennison Associates’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$117M	Sell	4,980,770 -1,777,236	-26%	-$45.4M	0.08%	114
2025 Q4	$196M	Sell	6,758,006 -5,496,113	-45%	-$141M	0.12%	71
2025 Q3	$231M	Buy	12,254,119 +1,144,714	+10%	+$18.1M	0.13%	66
2025 Q2	$156M	Sell	11,109,405 -251,470	-2%	-$3.53M	0.09%	95
2025 Q1	$178M	Sell	11,360,875 -978,917	-8%	-$13.8M	0.12%	86
2024 Q4	$172M	Buy	12,339,792 +676,295	+6%	+$7.41M	0.1%	93
2024 Q3	$108M	Buy	11,663,497 +91,803	+0.8%	+$906K	0.07%	130
2024 Q2	$108M	Sell	11,571,694 -604,621	-5%	-$5.47M	0.07%	117
2024 Q1	$121M	Buy	12,176,315 +3,110,233	+34%	+$23.2M	0.08%	102
2023 Q4	$29.3M	Buy	9,066,082 +4,633,907	+105%	+$12.6M	0.02%	280
2023 Q3	$23.5M	Buy	4,432,175 +138,209	+3%	+$1.18M	0.02%	291
2023 Q2	$40.9M	Buy	4,293,966 +2,079,476	+94%	+$23.1M	0.03%	216
2023 Q1	$24.4M	Buy	2,214,490 +816,211	+58%	+$11.8M	0.02%	300
2022 Q4	$20.7M	Buy	1,398,279 +8,663	+0.6%	+$151K	0.02%	317
2022 Q3	$26.6M	Buy	1,389,616 +954,597	+219%	+$21.6M	0.03%	276
2022 Q2	$9.27M	Buy	+435,019	New	+$8.92M	0.01%	391